Topical Collection on Melanoma

ISSN: 1523-3790 (Print) 1534-6269 (Online)

In this topical collection (59 articles)

Page of 3

  1. No Access

    Melanoma (RJ Sullivan, Section Editor)

    Immune Checkpoint Inhibitor Toxicity

    David J. Palmieri, Matteo S. Carlino Article:72

  2. No Access

    Melanoma (RJ Sullivan, Section Editor)

    Optimal Use of BRAF Targeting Therapy in the Immunotherapy Era

    Kevin Wood, Jason J. Luke Article:67

  3. Melanoma (RJ Sullivan, Section Editor)

    Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma

    Alberto Falk Delgado, Sayid Zommorodi, Anna Falk Delgado Article:54
    Download PDF (273KB) View Article

  4. No Access

    Melanoma (RJ Sullivan, Section Editor)

    Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies

    Kimberly M. Komatsubara, Richard D. Carvajal Article:45

  5. No Access

    Melanoma (RJ Sullivan, Section Editor)

    Influences of BRAF Inhibitors on the Immune Microenvironment and the Rationale for Combined Molecular and Immune Targeted Therapy

    Sangeetha M. Reddy, Alexandre Reuben, Jennifer A. Wargo Article:42

  6. No Access

    Melanoma (RJ Sullivan, Section Editor)

    Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls

    Eli P. Darnell, Meghan J. Mooradian, Erez N. Baruch… Article:39

  7. No Access

    Melanoma (RJ Sullivan, Section Editor)

    Treatment Options for Advanced Melanoma After Anti-PD-1 Therapy

    Nalan Akgul Babacan, Zeynep Eroglu Article:38

  8. No Access

    Melanoma (RJ Sullivan, Section Editor)

    Adjuvant Therapy for Melanoma

    Aya Agha, Ahmad A. Tarhini Article:36

  9. No Access

    Melanoma (RJ Sullivan, Section Editor)

    Cell Cycle Regulation and Melanoma

    Wen Xu, Grant McArthur Article:34

  10. No Access

    Melanoma (RJ Sullivan, Section Editor)

    Melanoma and Immune Checkpoint Inhibitors

    Masutaka Furue, Takamichi Ito, Naoko Wada, Maiko Wada… Article:29

  11. No Access

    Melanoma (RJ Sullivan, Section Editor)

    Mucosal Melanoma: a Literature Review

    Simon Skovsted Yde, Pia Sjoegren, Martin Heje, Lars B. Stolle Article:28

  12. No Access

    Melanoma (RJ Sullivan, Section Editor)

    Prognostic Biomarkers for Melanoma Immunotherapy

    Christopher G. Twitty, Laura A. Huppert, Adil I. Daud Article:25

  13. No Access

    Melanoma (RJ Sullivan, Section Editor)

    Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition

    Claire F. Friedman, Michael A. Postow Article:21

  14. No Access

    Melanoma (RJ Sullivan, Section Editor)

    The Role of Surgery for Melanoma in an Era of Effective Systemic Therapy

    Siavash Raigani, Sonia Cohen, Genevieve M. Boland Article:17

  15. No Access

    Melanoma (RJ Sullivan, Section Editor)

    Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma

    Romany A. N. Johnpulle, Douglas B. Johnson, Jeffrey A. Sosman Article:6

  16. Melanoma (RJ Sullivan, Section Editor)

    Transformation of Old Concepts for a New Era of Cancer Immunotherapy: Cytokine Therapy and Cancer Vaccines as Combination Partners of PD1/PD-L1 Inhibitors

    Romualdo Barroso-Sousa, Patrick A. Ott Article:1
    Download PDF (731KB) View Article

  17. No Access

    REVIEW

    Melanoma in Pediatric and Young Adult Patients

    Vernon K. Sondak, Jane L. Messina Pages 1-8

  18. No Access

    REVIEW

    For the Long Haul: Management of Long-Term Survivors after Melanoma Systemic Therapy

    Jordyn Silverstein, Neha Goyal, Katy K. Tsai Pages 1-14

  19. REVIEW

    Minimal Residual Disease-Adapted Therapy in Multiple Myeloma: Current Evidence and Opinions

    Mina Meseha, James Hoffman, Dickran Kazandjian, Ola Landgren… Pages 1-12
    Download PDF (741KB) View Article

  20. No Access

    REVIEW

    Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy

    Andrew D. Knight, Jason J. Luke Pages 1-14
Page of 3